Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$1.5 million.

  • CureVac N.V's Cash from Financing Activities fell 13.15% to -$1.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.9 million, marking a year-over-year decrease of 9.42%. This contributed to the annual value of -$5.5 million for FY2024, which is 102.20% down from last year.
  • Per CureVac N.V's latest filing, its Cash from Financing Activities stood at -$1.5 million for Q2 2025, which was down 7.37% from -$1.4 million recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Cash from Financing Activities peaked at $455.7 billion during Q2 2021, and registered a low of -$432.6 billion during Q4 2021.
  • Over the past 3 years, CureVac N.V's median Cash from Financing Activities value was -$1.3 million (recorded in 2023), while the average stood at $23.9 million.
  • In the last 5 years, CureVac N.V's Cash from Financing Activities crashed by 1,423,832.65% in 2021 and then spiked by 148.80% in 2023.
  • Over the past 5 years, CureVac N.V's Cash from Financing Activities (Quarterly) stood at -$432.6 billion in 2021, then surged by 100.01% to $34.0 million in 2022, then crashed by 104.46% to -$1.5 million in 2023, then grew by 9.85% to -$1.4 million in 2024, then dropped by 13.15% to -$1.5 million in 2025.
  • Its Cash from Financing Activities stands at -$1.5 million for Q2 2025, versus -$1.4 million for Q1 2025 and -$1.4 million for Q4 2024.